- recruiting
Tensi+ European Registry
This study is looking at a new device called Tensi+ for overactive bladder. It collects information from many patients to see how well it works and if it's safe over one year, helping us understand who it helps most.
France · Italy · United Kingdom - ongoing, recruitingHuman Pharmacology (Phase I)- Other
Feasibility and tolerability of 28 days intravaginal oxybutynin via the MedRing OAB system
This study is looking at a new way to treat overactive bladder in women. It's testing if a small ring inserted into the vagina, which releases medicine for 28 days, is safe and comfortable to use. The medicine is called oxybutynin.
Netherlands